RABIN KHETRAPAL: Open Payments
NPI 1629180310 · FREMONT, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,802 in 101 payments from 27 companies in 2025. Trend: 2023 $2,393 · 2024 $2,549 · 2025 $2,802
Food & beverage: $2,672Education: $130
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $274 |
| Otsuka America Pharmaceutical, Inc. | 9 | $202 |
| Amgen Inc. | 7 | $194 |
| Janssen Pharmaceuticals, Inc | 8 | $190 |
| Novo Nordisk Inc | 7 | $178 |
| Lundbeck LLC | 6 | $177 |
| Teva Pharmaceuticals USA, Inc. | 4 | $170 |
| Lilly USA, LLC | 8 | $167 |
| Procept Biorobotics Corporation | 1 | $149 |
| Vanda Pharmaceuticals Inc. | 5 | $141 |
Products named: REXULTI, CAPLYTA, EVENITY, AQUABEAM ROBOTIC SYSTEM, FANAPT, INVEGA SUSTENNA, Ozempic, LEQVIO.
Industry payments across CA — which companies pay providers there.
